LIPTRUZET 10 mg/20 mg, comprimé pelliculé — plaquette(s) aluminium de 90 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949005277
  • CIP7 4900527
  • CIS 63428879

What the source publishes

Holder
PHARMA LAB
Active ingredients
ATORVASTATINE, ÉZÉTIMIBE, ATORVASTATINE CALCIQUE TRIHYDRATÉE
Form
comprimé pelliculé
Package
plaquette(s) aluminium de 90 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Arrêt de commercialisation (le médicament n'a plus d'autorisation)
Authorised on
2023-03-27
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949005277
{
  "cis": "63428879",
  "cip7": "4900527",
  "form": "comprimé pelliculé",
  "name": "LIPTRUZET 10 mg/20 mg, comprimé pelliculé — plaquette(s) aluminium de 90 comprimé(s)",
  "cip13": "3400949005277",
  "holder": "PHARMA LAB",
  "routes": [
    "orale"
  ],
  "holders": [
    "PHARMA LAB"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "58.13",
  "authorisedOn": "2023-03-27",
  "compositions": [
    {
      "name": "ATORVASTATINE",
      "nature": "FT",
      "strength": "20 mg",
      "linkageNumber": "2",
      "substanceCode": "19809",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ÉZÉTIMIBE",
      "nature": "SA",
      "strength": "10 mg",
      "linkageNumber": "1",
      "substanceCode": "73242",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "2",
      "substanceCode": "92464",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "2.76",
  "medicinePrice": "55.37",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LIPTRUZET 10 mg/20 mg, comprimé pelliculé",
  "marketingStatus": "Arrêt de commercialisation (le médicament n'a plus d'autorisation)",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) aluminium de 90 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2025-04-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATORVASTATINE",
    "ÉZÉTIMIBE",
    "ATORVASTATINE CALCIQUE TRIHYDRATÉE"
  ],
  "authorisationProcedure": "Autorisation d'importation parallèle",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949005277"